Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;78(1):e18-e20.
doi: 10.1016/j.eururo.2020.04.043. Epub 2020 Apr 27.

VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic

Valeria Panebianco  1 , Francesco Del Giudice  2 , Costantino Leonardo  3 , Alessandro Sciarra  3 , Carlo Catalano  4 , James W F Catto  5
Affiliations
Comment

VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic

Valeria Panebianco et al. Eur Urol. 2020 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Possible alternatives in the diagnostic and therapeutic management of bladder cancer during the COVID-19 pandemic. (A) Work-up for gross hematuria. * Elective gross hematuria work-up (ie, not requiring emergency interventions or immediate hospitalization). (B) Work-up for non–muscle-invasive bladder cancer (NMIBC) candidate for Re-TURBT. * Except for Ta low-grade/G1 tumors and primary carcinoma in situ. (C) Work-up for muscle-invasive bladder cancer (MIBC). * Except for Ta low-grade/G1 tumors and primary carcinoma in situ. CT = computed tomography; MRI = magnetic resonance imaging; VI-RADS = Vesical Imaging-Reporting and Data System; TURBT = transurethral resection of bladder tumor; EUA = European Association of Urology; BCG = bacillus Calmette-Guérin; Re-TURBT = repeat TURBT; RC = radical cystectomy; NAC = neoadjuvant systemic chemotherapy; HG = high grade; AACCI = age-adjusted Charlson comorbidity index.
See this image and copyright information in PMC

Comment on

References

    1. Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. - PMC - PubMed
    1. Panebianco V., Narumi Y., Altun E. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System) Eur Urol. 2018;74:294–306. - PMC - PubMed
    1. Woo S., Panebianco V., Narumi Y., et al. Diagnostic performance of Vesical Imaging Reporting and Data System for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Oncol. In press. 10.1016/j.euo.2020.02.007. - DOI - PMC - PubMed
    1. Del Giudice F., Barchetti G., De Berardinis E. Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur Urol. 2020;77:101–109. - PubMed
    1. Gillessen Sommer S., Powles T. Advice regarding systemic therapy in patients with urological cancers during the COVID-19 pandemic. Eur Urol. In press. - PMC - PubMed